MUFG Securities Americas’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$905K Buy
4,031
+99
+3% +$24.7K 0.06% 279
2025
Q4
$947K Sell
3,932
-17
-0.4% -$4.35K 0.06% 270
2025
Q3
$1.08M Buy
3,949
+699
+22% +$191K 0.07% 245
2025
Q2
$839K Buy
3,250
+651
+25% +$155K 0.07% 243
2025
Q1
$582K Buy
2,599
+432
+20% +$101K 0.07% 260
2024
Q4
$496K Buy
+2,167
New +$522K 0.06% 263

Other funds holding RMD

MUFG Securities Americas's RMD Position: Q1 2026 in Review

MUFG Securities Americas increased its ResMed (RMD) stake by 2.5% in Q1 2026, buying an estimated $24.7K and bringing the position to 4,031 shares worth $905K. The position accounts for 0.06% of the portfolio, ranked #279.

MUFG Securities Americas first reported a position in RMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.08M in Q3 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • MUFG Securities Americas held 4,031 shares of ResMed worth $905K as of Q1 2026.
  • MUFG Securities Americas bought 99 ResMed shares in Q1 2026, an estimated $24.7K.
  • ResMed made up 0.06% of MUFG Securities Americas's portfolio in Q1 2026, its #279 holding.
  • MUFG Securities Americas first reported a position in ResMed in Q4 2024 and has held it in 6 quarters since.
  • MUFG Securities Americas's ResMed position peaked at $1.08M in Q3 2025.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on MUFG Securities Americas's 13F filing for Q1 2026, filed 11 May 2026.